These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 10084633

  • 1. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA, LamLit Study Group.
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [Abstract] [Full Text] [Related]

  • 3. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [Abstract] [Full Text] [Related]

  • 4. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM, Weisler RH, Raines SR, Macfadden W, BOLDER Study Group.
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [Abstract] [Full Text] [Related]

  • 6. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Calabrese JR, Huffman RF, White RL, Edwards S, Thompson TR, Ascher JA, Monaghan ET, Leadbetter RA.
    Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
    [Abstract] [Full Text] [Related]

  • 7. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK.
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [Abstract] [Full Text] [Related]

  • 8. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
    Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J.
    J Clin Psychiatry; 2002 Apr; 63(4):337-44. PubMed ID: 12000208
    [Abstract] [Full Text] [Related]

  • 9. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB, McElroy SL, Keck PE, Deldar A, Adams DH, Tohen M, Williamson DJ.
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group.
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
    Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET.
    J Clin Psychiatry; 2000 Nov; 61(11):841-50. PubMed ID: 11105737
    [Abstract] [Full Text] [Related]

  • 13. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.
    Suppes T, Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R.
    J Affect Disord; 2008 Dec; 111(2-3):334-43. PubMed ID: 18358540
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L, Berk M, Vorster M.
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J, Lamictal 605 Study Group.
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [Abstract] [Full Text] [Related]

  • 16. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J, Lamictal 606 Study Group.
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [Abstract] [Full Text] [Related]

  • 17. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z, Gao K, Kemp DE, Chan PK, Serrano MB, Conroy C, Fang Y, Ganocy SJ, Findling RL, Calabrese JR.
    Psychopharmacol Bull; 2010 Apr; 43(4):5-21. PubMed ID: 21240149
    [Abstract] [Full Text] [Related]

  • 18. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.
    Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, Kotarski M, Williams C, Wozniak J.
    CNS Neurosci Ther; 2010 Apr; 16(2):91-102. PubMed ID: 20415838
    [Abstract] [Full Text] [Related]

  • 19. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
    Hirschfeld RM, Keck PE, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F.
    Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
    [Abstract] [Full Text] [Related]

  • 20. Lamotrigine in patients with bipolar disorder and cocaine dependence.
    Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L.
    J Clin Psychiatry; 2003 Feb; 64(2):197-201. PubMed ID: 12633129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.